-transparent.png){kind=logo}
Immunogenic hyperthyroidism rarely develops after radioiodine elimination of focal autonomous thyroid tissue. We observed this phenomenon in 8 patients between 1989 and 1992. The occurrence of immunogenic hyperthyroidism shortly after elimination of autonomous nodules has not been studied nor is it properly understood. Most studies known today describe the development of autonomous nodules in the course of immunogenic hyperthyroidism or ignore the chronologic order of occurrence. The possibility that immunogenic hyperthyroidism may occur after radioiodine therapy of autonomous nodules, makes a consequent follow-up within the first year following radioiodine therapy mandatory.
B Boddenberg, and
E Voth, and
H Schicha
May 1999,
Medizinische Klinik (Munich, Germany : 1983),
B Boddenberg, and
E Voth, and
H Schicha
June 1988,
Nuklearmedizin. Nuclear medicine,
B Boddenberg, and
E Voth, and
H Schicha
January 1956,
The British journal of radiology,
B Boddenberg, and
E Voth, and
H Schicha
November 1959,
Nuclear-Medizin,
B Boddenberg, and
E Voth, and
H Schicha
January 2012,
World journal of nuclear medicine,
B Boddenberg, and
E Voth, and
H Schicha
May 2004,
The Journal of the Association of Physicians of India,
B Boddenberg, and
E Voth, and
H Schicha
January 1985,
Acta medica Scandinavica,
B Boddenberg, and
E Voth, and
H Schicha
November 1982,
MMW, Munchener medizinische Wochenschrift,
B Boddenberg, and
E Voth, and
H Schicha
June 1970,
Acta radiologica: therapy, physics, biology,
B Boddenberg, and
E Voth, and
H Schicha
May 1954,
The Journal of clinical endocrinology and metabolism,
